Delivery Order SPE2DB20D1109-SPE2DB23FN30M
- Not listed
- This federal contract award, identified as SPE2DB22D3102|SPE2DB25FL0LF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobradex Eye Ointment 3.5GM, a medical product, with a ceiling value of $1,094.46 and a completion date of March 13, 2025. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,767.50 Firm Fixed Price Delivery Order is for the supply of 4564657159 - Tobradex Eye Ointment 3.5 grams. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award, identified as SPE2DX15D1022|SPE2DX25FUYMH, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Tobradex Eye Ointment, a prescription medication, with a ceiling value of $1,162.14 and a completion date of October 7, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, through its...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY6HS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.51 firm fixed-price delivery order is for the supply of TOBRADEX EYE OINTMENT 3.5GM. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product, with a ceiling value of $1,622.97 and a performance period through July 2, 2025. The contract is a firm-fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tobradex Eye Ointment 3.5GM. The contract has a firm fixed price, a ceiling value of $1,108.89, and a period of performance through March 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award SPE2DB22D2007|SPE2DB24FH9JH was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TOBRADEX EYE OINTMENT 3.5GM. The contract has a ceiling value of $2,063.34 and a completion date of February 7, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly for...
- This federal contract award, with the ID SPE2DB22D3301|SPE2DB25FX3TG, is for the delivery of 4,566,110,787 units of Tobradex eye ointment (3.5 grams) to the Defense Logistics Agency (DLA). The ceiling value of this Firm Fixed Price Delivery Order contract is $1,049.73, and the ultimate completion date is October 16, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. This contract is not designated as a...
- This federal contract award, valued at $1,082.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, a medical product used for eye care. The contract has an ultimate completion date of January 28, 2025 and is structured as a Firm Fixed Price Delivery Order. This award does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.47 Firm Fixed Price Delivery Order contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN30MDelivery Order
This federal contract award, with an award ID of SPE2DB20D1109|SPE2DB23FN30M, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Tobradex Eye Ointment, 3.5 grams, with a total ceiling value of $2,212.65. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has a period of performance through January 10, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies, including the DLA. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/9/23 |